$4.70
+0.370 (+8.55%)
At Close: Jul 31, 2026
ENDRA Life Sciences Provides Update on U.S. Regulatory Strategy for its TAEUS® System
09:05pm, Wednesday, 09'th Feb 2022 Kwhen FinanceENDRA Life Sciences to Present at the H.C. Wainwright BioConnect Virtual Conference
07:00am, Wednesday, 05'th Jan 2022
ANN ARBOR, Mich.--(BUSINESS WIRE)--ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of enhanced ultrasound technologies, announces that management will present a company overview at the H.C.
Forget Bargains, Play 5 Stocks With Rising P/E Instead
12:57pm, Thursday, 30'th Dec 2021 Zacks Investment Research
Forget undervalued stocks, there is room for upside even in stocks with rising P/E.
Forget Bargains, Play 5 Stocks With Rising P/E Instead
09:12am, Thursday, 30'th Dec 2021
Forget undervalued stocks, there is room for upside even in stocks with rising P/E.
Traders should follow this: ENDRA Life Sciences Inc. (NASDAQ:NDRA), Tanzanian Gold Corporation (AMEX:TRX)
04:46am, Friday, 24'th Dec 2021 Stock Equity
ENDRA Life Sciences Inc. (NASDAQ:NDRA) with the stream of 6.79% also noticed, India Tanzanian Gold Corporation (AMEX:TRX) encountered a rapid change of -4.18% in the last hour of Thursdays trading The post Traders should follow this: ENDRA Life Sciences Inc. (NASDAQ:NDRA), Tanzanian Gold Corporation (AMEX:TRX) appeared first on Stocks Equity .
ENDRA Life Sciences (NASDAQ:NDRA) Lowered to Hold at Zacks Investment Research
06:06am, Wednesday, 15'th Dec 2021 Dakota Financial News
Zacks Investment Research lowered shares of ENDRA Life Sciences (NASDAQ:NDRA) from a buy rating to a hold rating in a research note issued to investors on Saturday morning, Zacks.com reports. According to Zacks, ENDRA Life Sciences Inc. is a developer of enhanced ultrasound technologies. ENDRA Life Sciences Inc. is based in Ann Arbor, United States. []
Goldman Sachs Group Inc. Makes New $104,000 Investment in ENDRA Life Sciences Inc. (NASDAQ:NDRA)
09:12am, Monday, 13'th Dec 2021 Transcript Daily
Goldman Sachs Group Inc. acquired a new position in ENDRA Life Sciences Inc. (NASDAQ:NDRA) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 47,709 shares of the companys stock, valued at approximately $104,000. Goldman Sachs Group Inc. owned 0.11% of ENDRA Life Sciences at []
Zacks Investment Research Downgrades ENDRA Life Sciences (NASDAQ:NDRA) to Hold
06:36am, Monday, 13'th Dec 2021 Transcript Daily
ENDRA Life Sciences (NASDAQ:NDRA) was downgraded by Zacks Investment Research from a buy rating to a hold rating in a research note issued on Saturday, Zacks.com reports. According to Zacks, ENDRA Life Sciences Inc. is a developer of enhanced ultrasound technologies. ENDRA Life Sciences Inc. is based in Ann Arbor, United States. NASDAQ NDRA []
Tips For Effortless money: Ardelyx, Inc. (NASDAQ:ARDX 12.86%), ENDRA Life Sciences Inc. (NASDAQ:NDRA -4.84%)
11:22pm, Thursday, 09'th Dec 2021 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 The post Tips For Effortless money: Ardelyx, Inc. (NASDAQ:ARDX 12.86%), ENDRA Life Sciences Inc. (NASDAQ:NDRA -4.84%) appeared first on Stocks Equity .
ENDRA Life Sciences Inc. (NASDAQ: NDRA): Don’t Ditch NDRA Stock In 2021
02:00pm, Wednesday, 08'th Dec 2021 Marketing Sentinel
In the last trading session, 1.15 million ENDRA Life Sciences Inc. (NASDAQ:NDRA) shares changed hands as the company’s beta touched 1.24. With the company’s per share price at $0.87 changed hands at $0.07 or 8.31% during last session, the market valuation stood at $38.53M. NDRA’s last price was a discount, traded about -256.32% off its … ENDRA Life Sciences Inc. (NASDAQ: NDRA): Don’t Ditch NDRA Stock In 2021 Read More »
Zacks Investment Research Upgrades ENDRA Life Sciences (NASDAQ:NDRA) to Buy
07:16am, Tuesday, 30'th Nov 2021 Dakota Financial News
Zacks Investment Research upgraded shares of ENDRA Life Sciences (NASDAQ:NDRA) from a hold rating to a buy rating in a report issued on Monday morning, Zacks.com reports. They currently have $1.00 target price on the stock. According to Zacks, ENDRA Life Sciences Inc. is a developer of enhanced ultrasound technologies. ENDRA Life Sciences Inc. is []
ENDRA Life Sciences Expands Pharmaceutical Partnerships with VGI Health Technology to Provide TAEUS for Patient Screening and Biomarker Measurement for Phase 2 Study
01:00pm, Monday, 29'th Nov 2021 Business Wire
ANN ARBOR, Mich. & SYDNEY--(BUSINESS WIRE)--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), and VGI Health Technology Limited (NSX: VTL), a clinical-stage biotechnology company specializing in developing and commercializing evidence-based nutraceuticals and pharmaceuticals, announce today the signing of a collaboration agreement to incorporate ENDRAs proprietary TAEUS technology to support patient screening and biomarker measurement during VG
Head-To-Head Review: ADM Tronics Unlimited (OTCMKTS:ADMT) & ENDRA Life Sciences (NASDAQ:NDRA)
08:10am, Monday, 29'th Nov 2021 Dakota Financial News
ADM Tronics Unlimited (OTCMKTS:ADMT) and ENDRA Life Sciences (NASDAQ:NDRA) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, analyst recommendations, profitability, institutional ownership and risk. Earnings & Valuation This table compares ADM Tronics Unlimited and ENDRA Life Sciences []
ENDRA Life Sciences (NASDAQ:NDRA) Downgraded by Zacks Investment Research to Hold
06:34am, Friday, 26'th Nov 2021 Dakota Financial News
ENDRA Life Sciences (NASDAQ:NDRA) was downgraded by Zacks Investment Research from a buy rating to a hold rating in a research note issued on Wednesday, Zacks.com reports. According to Zacks, ENDRA Life Sciences Inc. is a developer of enhanced ultrasound technologies. ENDRA Life Sciences Inc. is based in Ann Arbor, United States. Shares of []
ENDRA Life Sciences (NASDAQ:NDRA) Downgraded to Hold at Zacks Investment Research
09:00am, Thursday, 25'th Nov 2021 Transcript Daily
Zacks Investment Research downgraded shares of ENDRA Life Sciences (NASDAQ:NDRA) from a buy rating to a hold rating in a report published on Wednesday, Zacks.com reports. According to Zacks, “ENDRA Life Sciences Inc. is a developer of enhanced ultrasound technologies. ENDRA Life Sciences Inc. is based in Ann Arbor, United States. “ Shares of NDRA […]
Sign In
Buy NDRA